Works matching DE "ROFECOXIB"
Results: 207
Quebec allows Vioxx class-action suit.
- Published in:
- CMAJ: Canadian Medical Association Journal Supplement, 2007, v. 176, n. 1, p. 20, doi. 10.1503/cmaj.061600
- By:
- Publication type:
- Article
Rofecoxib, but not celecoxib, increases the risk of thromboembolic cardiovascular events in young adults—a nationwide registry-based study.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 6, p. 619, doi. 10.1007/s00228-010-0789-2
- By:
- Publication type:
- Article
Unbalanced reporting of benefits and harms in abstracts on rofecoxib.
- Published in:
- European Journal of Clinical Pharmacology, 2010, v. 66, n. 4, p. 341, doi. 10.1007/s00228-010-0791-8
- By:
- Publication type:
- Article
Was the thrombotic risk of rofecoxib predictible from the French Pharmacovigilance Database before 30 September 2004?
- Published in:
- European Journal of Clinical Pharmacology, 2008, v. 64, n. 8, p. 829, doi. 10.1007/s00228-008-0497-3
- By:
- Publication type:
- Article
Transfer of rofecoxib into human milk.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 5/6, p. 405, doi. 10.1007/s00228-005-0937-2
- By:
- Publication type:
- Article
The effects of 3-benzoyl-1-methyl-4-phenyl-4-piperidinolhydrochloride (C1), indomethacin, nimesulide and rofecoxib on cyclooxygenase activities in carrageenan-induced paw edema model.
- Published in:
- Turkish Journal of Medical Sciences, 2010, v. 40, n. 5, p. 723, doi. 10.3906/sag-0908-187
- Publication type:
- Article
Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999–2002.
- Published in:
- Current Medical Research & Opinion, 2009, v. 25, n. 6, p. 1535, doi. 10.1185/03007990902953286
- By:
- Publication type:
- Article
The VIOXX in prostate cancer prevention study: cardiovascular events observed in the rofecoxib 25 mg and placebo treatment groups.
- Published in:
- Current Medical Research & Opinion, 2007, v. 23, n. 9, p. 2063, doi. 10.1185/030079907X219526
- By:
- Publication type:
- Article
Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization.
- Published in:
- Current Medical Research & Opinion, 2007, v. 23, n. 8, p. 1859, doi. 10.1185/030079907X210561
- By:
- Publication type:
- Article
The efficacy of rofecoxib 50 mg and hydrocodone/acetaminophen 7.5/750 mg in patients with post-arthroscopic pain.
- Published in:
- Current Medical Research & Opinion, 2007, v. 23, n. 1, p. 195, doi. 10.1185/030079907X162647
- By:
- Publication type:
- Article
Unmet Needs in Non-steroidal Anti-inflammatory Drug-induced Upper Gastrointestinal Diseases.
- Published in:
- Drugs, 2006, v. 66, p. 15, doi. 10.2165/00003495-200666001-00004
- By:
- Publication type:
- Article
Selective COX-2 Inhibitors: A Review of Their Structure-Activity Relationships.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2011, v. 10, n. 4, p. 655
- By:
- Publication type:
- Article
A Sharp Idea.
- Published in:
- Orthopedics, 2006, v. 29, n. 10, p. 877, doi. 10.3928/01477447-20061001-02
- Publication type:
- Article
Effect of Rofecoxib on Pain Caused by Osteoid Osteoma.
- Published in:
- Orthopedics, 2004, v. 27, n. 11, p. 1188, doi. 10.3928/0147-7447-20041101-17
- By:
- Publication type:
- Article
The dramatic breakdown of the market orientation concept in the pharmaceutical industry: lessons from Vioxx.
- Published in:
- Journal of Strategic Marketing, 2019, v. 27, n. 3, p. 227, doi. 10.1080/0965254X.2017.1384752
- By:
- Publication type:
- Article
Despite its Effective COVID Vaccine, Pfizer Is Not Our Pfriend.
- Published in:
- CounterPunch, 2022, p. 1
- By:
- Publication type:
- Article
Comparative Efficacy and Safety of Non-Steroidal Anti-Inflammatory Drugs in Patients With Juvenile Idiopathic Arthritis: A Systematic Review and Network Meta-analysis.
- Published in:
- Indian Pediatrics, 2021, v. 58, n. 2, p. 162, doi. 10.1007/s13312-021-2155-0
- By:
- Publication type:
- Article
The hazards of rapid approval of new drugs.
- Published in:
- 2016
- By:
- Publication type:
- Editorial
Stable Discovery of Interpretable Subgroups via Calibration in Causal Studies.
- Published in:
- International Statistical Review, 2020, v. 88, p. S135, doi. 10.1111/insr.12427
- By:
- Publication type:
- Article
Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies.
- Published in:
- PLoS Medicine, 2011, v. 8, n. 9, p. 1, doi. 10.1371/journal.pmed.1001098
- By:
- Publication type:
- Article
Author's Reply.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Merck's Actions Surrounding Vioxx.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Perceived barriers to paracetamol (acetaminophen) prescribing, especially following rofecoxib withdrawal from the market.
- Published in:
- Clinical Rheumatology, 2009, v. 28, n. 5, p. 509, doi. 10.1007/s10067-008-1077-8
- By:
- Publication type:
- Article
The effect of Cox-2 specific inhibition on direct fracture healing in the rabbit tibia.
- Published in:
- Journal of Orthopaedic Science, 2011, v. 16, n. 1, p. 93, doi. 10.1007/s00776-010-0016-0
- By:
- Publication type:
- Article
Effect of a Selective Cyclooxygenase-2 Inhibitor on Renal Scarring.
- Published in:
- European Surgical Research, 2006, v. 38, n. 5, p. 451, doi. 10.1159/000095088
- By:
- Publication type:
- Article
Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases.
- Published in:
- British Journal of Clinical Pharmacology, 2008, v. 65, n. 6, p. 927, doi. 10.1111/j.1365-2125.2008.03121.x
- By:
- Publication type:
- Article
What therapies have replaced rofecoxib in Ireland?
- Published in:
- British Journal of Clinical Pharmacology, 2007, v. 64, n. 4, p. 536, doi. 10.1111/j.1365-2125.2007.02918.x
- By:
- Publication type:
- Article
Characterizing new users of NSAIDs before and after rofecoxib withdrawal.
- Published in:
- British Journal of Clinical Pharmacology, 2007, v. 63, n. 4, p. 494, doi. 10.1111/j.1365-2125.2006.02784.x
- By:
- Publication type:
- Article
Rofecoxib is a potent inhibitor of cytochrome P450 1A2: studies with tizanidine and caffeine in healthy subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 62, n. 3, p. 345, doi. 10.1111/j.1365-2125.2006.02653.x
- By:
- Publication type:
- Article
The effect of the withdrawal of rofecoxib on prescribing patterns of COX-2 inhibitors in Scotland.
- Published in:
- British Journal of Clinical Pharmacology, 2006, v. 62, n. 3, p. 366, doi. 10.1111/j.1365-2125.2006.02691.x
- By:
- Publication type:
- Article
The NSAID roller coaster: more about rofecoxib.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Population pharmacokinetic modelling of the enterohepatic recirculation of diclofenac and rofecoxib in rats.
- Published in:
- British Journal of Pharmacology, 2008, v. 153, n. 5, p. 1072, doi. 10.1038/sj.bjp.0707643
- By:
- Publication type:
- Article
SIMULTANEOUS ESTIMATION OF TIZANIDINE HYDROCHLORIDE AND ROFECOXIB BY RATIO DERIVATIVE SPECTROSCOPIC METHOD IN TABLET.
- Published in:
- Pharma Science Monitor, 2014, v. 5, n. 2, Supp 1, p. 141
- By:
- Publication type:
- Article
Merck and Vioxx: An Examination of an Ethical Decision-Making Model.
- Published in:
- Journal of Business Ethics, 2007, v. 76, n. 4, p. 451, doi. 10.1007/s10551-006-9302-3
- By:
- Publication type:
- Article
The ADVANTAGE Seeding Trial: A Review of Internal Documents.
- Published in:
- Annals of Internal Medicine, 2008, v. 149, n. 4, p. 251, doi. 10.7326/0003-4819-149-4-200808190-00006
- By:
- Publication type:
- Article
SOLUBILITY AND DISSOLUTION IMPROVEMENT OF ROFECOXIB USING SOLID DISPESION TECHNIQUE.
- Published in:
- Pakistan Journal of Pharmaceutical Sciences, 2008, v. 21, n. 4, p. 350
- By:
- Publication type:
- Article
Rofecoxib for dysmenorrhoea: meta-analysis using individual patient data.
- Published in:
- BMC Women's Health, 2004, v. 4, p. 5, doi. 10.1186/1472-6874-4-5
- By:
- Publication type:
- Article
Pharmaceutical industry under fire.
- Published in:
- Contemporary Pediatrics, 2005, v. 22, n. 1, p. 11
- Publication type:
- Article
Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients.
- Published in:
- Nephrology Dialysis Transplantation, 2009, v. 24, n. 4, p. 1182
- By:
- Publication type:
- Article
Use of Disproportionality Analysis to Identify Previously Unknown Drug-Associated Causes of Cardiac Arrhythmias Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2021, v. 26, n. 4, p. 341, doi. 10.1177/1074248420984082
- By:
- Publication type:
- Article
The Risk of Acute Myocardial Infarction With Etodolac Is Not Increased Compared to Naproxen: A Historical Cohort Analysis of a Generic COX-2 Selective Inhibitor.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2008, v. 13, n. 4, p. 252, doi. 10.1177/1074248408323136
- By:
- Publication type:
- Article
TLC determination of piroxicam, tenoxicam, celecoxib and rofecoxib in biological material.
- Published in:
- Journal of Analytical Chemistry, 2015, v. 70, n. 3, p. 351, doi. 10.1134/S106193481503020X
- By:
- Publication type:
- Article
Separation and determination of rofecoxib and its degradation products by TLC chromatography.
- Published in:
- Journal of Analytical Chemistry, 2009, v. 64, n. 6, p. 623, doi. 10.1134/S106193480906015X
- By:
- Publication type:
- Article
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS - NO MORE SAFE FOR CARDIAC PATIENTS.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia.
- Published in:
- Haemophilia, 2006, v. 12, n. 5, p. 514, doi. 10.1111/j.1365-2516.2006.01311.x
- By:
- Publication type:
- Article
Prescription of nonselective NSAIDs, coxibs and gastroprotective agents in the era of rofecoxib withdrawal - a 617 400-patient study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 36, n. 8, p. 790, doi. 10.1111/apt.12028
- By:
- Publication type:
- Article
The story of Vioxx—no pain and a lot of gain: ethical concerns regarding conduct of the pharmaceutical industry.
- Published in:
- Journal of Anesthesia, 2006, v. 20, n. 4, p. 348, doi. 10.1007/s00540-006-0432-7
- By:
- Publication type:
- Article
Increased toxicity and lack of efficacy of Rofecoxib in combination with chemotherapy for treatment of metastatic colorectal cancer: A phase II study.
- Published in:
- International Journal of Cancer, 2003, v. 105, n. 6, p. 868, doi. 10.1002/ijc.11164
- By:
- Publication type:
- Article
Pharmacovigilance: a vital tool or a wasted eff ort?
- Published in:
- 2013
- By:
- Publication type:
- Proceeding
NSAID-Induced Adverse Drug Reaction: Mechanism and Management.
- Published in:
- Indian Journal of Forensic Medicine & Toxicology, 2021, v. 15, n. 2, p. 207, doi. 10.37506/ijfmt.v15i2.14308
- By:
- Publication type:
- Article